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The epithelial-mesenchymal transition (EMT) is a key
developmental program that is often activated during
cancer invasion and metastasis. We here report that
the induction of an EMT in immortalized humanmam-
mary epithelial cells (HMLEs) results in the acquisition
of mesenchymal traits and in the expression of stem-
cell markers. Furthermore, we show that those cells
have an increased ability to form mammospheres,
a property associated with mammary epithelial stem
cells. Independent of this, stem cell-like cells isolated
from HMLE cultures form mammospheres and ex-
pressmarkers similar to those ofHMLEs that haveun-
dergone an EMT. Moreover, stem-like cells isolated
either from mouse or human mammary glands or
mammary carcinomas express EMTmarkers. Finally,
transformed human mammary epithelial cells that
have undergone an EMT form mammospheres, soft
agar colonies, and tumors more efficiently. These
findings illustrate a direct link between the EMT and
the gain of epithelial stem cell properties.
INTRODUCTION
The epithelial-mesenchymal transition (EMT) and the reverse
process, termed the mesenchymal-epithelial transition (MET),
play central roles in embryogenesis (Hay, 1995; Perez-Pomares
and Munoz-Chapuli, 2002; Thiery and Sleeman, 2006). For ex-
ample, during early embryonic development, the mesoderm704 Cell 133, 704–715, May 16, 2008 ª2008 Elsevier Inc.generated by EMTs develops into multiple tissue types, and later
in development, mesodermal cells generate epithelial organs,
such as the kidney and ovary, via METs (Davies, 1996).
Developmental genetics research has revealed a number of
pleiotropically acting transcription factors that play critical roles
in embryogenesis by orchestrating EMTs (Briegel, 2006). In
recent years, these embryonic transcription factors have been
found to confer malignant traits, such as motility, invasiveness,
and resistance to apoptosis, on neoplastic cells (Cheng et al.,
2007; Comijn et al., 2001; Hartwell et al., 2006; Huber et al.,
2005; Mani et al., 2007; Oft et al., 2002; Peinado et al., 2007; Sav-
agner et al., 2005; Yang et al., 2004, 2006). Some of these tran-
scription factors also appear to play key roles in wound healing
(Savagner et al., 2005).
Independent of these findings, a large body of research has
described stem cells in normal tissues, which are capable of
renewing themselves through asymmetrical cell division while
simultaneously generating committed progenitor cells whose
descendants may eventually differentiate and carry out tissue-
specific functions (Reya et al., 2001). More recently, studies of
neoplastic tissues has provided evidence of self-renewing,
stem-like cells within tumors, which have been called cancer
stem cells (CSCs). CSCs constitute a small minority of neoplastic
cells within a tumor and are defined operationally by their ability
to seed new tumors. For this reason, they have also been termed
‘‘tumor-initiating cells’’ (Reya et al., 2001).
CSCs were first identified in the hematopoietic system (Bonnet
and Dick, 1997); more recently, however, they have also been dis-
covered in solid tumors, including those arising in the breast, co-
lon, and brain (Al-Hajj et al., 2003; O’Brien et al., 2007; Ricci-Vitiani
et al., 2007; Singh et al., 2004). For example, a small subpopula-
tion of cancer cells is present within some human breast tumors
that exhibits a CD44high/CD24low antigenic phenotype; these cells
are highly enriched for tumor-initiating cells in comparison to the
majority of carcinoma cells of the CD44low/CD24high phenotype
found in the same tumors (Al-Hajj et al., 2003).
During the process of tumor metastasis, which is often en-
abled by EMTs (Thiery, 2003), disseminated cancer cells would
seem to require self-renewal capability, similar to that exhibited
by stem cells, in order to spawn macroscopic metastases. This
raises the possibility that the EMT process, which enables can-
cer cell dissemination, may also impart a self-renewal capability
to disseminating cancer cells. Indeed, the metastatic process is
at least superficially similar to the processes that occur during
tissue repair and regeneration and enable adult stem cells to
exit tissue reservoirs (such as the bone marrow), enter and sur-
vive in the circulation, and exit into secondary tissue sites, where
they proliferate, differentiate, and participate in tissue recon-
struction (Kondo et al., 2003).
Together, these diverse lines of evidence suggested a possible
link between less differentiated stem cells and the mesenchy-
mal-appearing cells generated by EMTs. In this report, we
used a variety of human and murine mammary epithelial cells
to address the possible association between the EMT and the
formation of stem cells. We show that cells that have undergone
an EMT behave in many respects similarly to stem cells isolated
from normal or neoplastic cell populations.
RESULTS
EMTs Generate Stem Cell-like Cells
To determine whether adult cells that have undergone an EMT and
adult stem cells have similar traits, we induced an EMT in nontu-
morigenic, immortalized human mammaryepithelial cells (HMLEs)
by ectopic expression of either the Twist or Snail transcription
factors, both of which are capable of inducing EMTs in epithelial
cells (Batlle et al., 2000; Cano et al., 2000; Yang et al., 2004,
2006). As anticipated, the resulting cells acquired fibroblast-like,
mesenchymal appearances (Figure 1A), downregulated the
expression of mRNAsencoding epithelial markers (such as E-cad-
herin), and upregulated mRNAs encoding mesenchymal markers
(such as N-cadherin, vimentin, and fibronectin) (Figures 1B and
S1). We then used flow cytometry analysis to sort the cells based
on the expression CD44 and CD24, two cell-surface markers
whose expression in the CD44high/CD24low configuration is asso-
ciated with both human breast CSCs and normal mammary
epithelial stem cells (Al-Hajj et al., 2003; Sleeman et al., 2006).
We found that most if not all of the mesenchymal-like cells
generated by these EMTs acquired a CD44high/CD24low expres-
sion pattern—precisely the antigenic phenotype that has been
ascribed to neoplastic mammary stem cells (Al-Hajj et al.,
2003; Liao et al., 2007; Sleeman et al., 2006); this shift was not
observed in cells expressing a control vector (Figure 1C). Simi-
larly, induction of an EMT in HMLEs by exposure to TGFb1
resulted in the appearance of mesenchymal-looking cells
(Figure 1A) and the acquisition of the CD44high/CD24low antigen
phenotype (Figure 1C). These various observations showed
that the HMLEs that have undergone an EMT develop antigenic
markers associated with normal and neoplastic mammary stem
cells.Both human and murine mammary epithelial stem cells can
form mammospheres in suspension culture (Dontu et al., 2003;
Liao et al., 2007); in addition, following implantation into the
mammary stromal fat pad, the murine stem cells can reconstitute
an entire mammary ductal tree (Shackleton et al., 2006; Stingl
et al., 2006). Our own studies (Liao et al., 2007) and those of
others (Liu et al., 2006; Moraes et al., 2007) have demonstrated
that the ability to form mammospheres in vitro depends on the
presence of self-renewing, gland-reconstituting stem cells within
the population. Moreover, the use of mammosphere assay to
assess the presence of stem cells in a population of mammary
epithelial cells (MECs) is further validated by the fact that a single
murine mammosphere can regenerate an entire mammary duc-
tal tree when implanted into a cleared mouse mammary stromal
fat pad (Moraes et al., 2007).
With these findings in mind, we examined the mammosphere-
forming ability of the HMLEs forced to undergo an EMT by ec-
topic expression of Snail or Twist. Significantly, we found that
the HMLEs that underwent an EMT formed >30-fold more mam-
mospheres than did HMLEs infected with the corresponding
control vector (Figure 1D). In addition, after we induced an
EMT in HMLE cells by exposing them to TGFb1, these cells
formed at least >40-fold more mammospheres than did un-
treated control cells (Figure 1D). Based on this functional assay,
we concluded that the cells generated by an EMT acquired yet
another attribute of mammary stem cells.
To further assess whether the appearance of the CD44high/
CD24low cells and the gain of mammosphere-forming ability
are correlated with the EMT process, we activated either Snail
or Twist function reversibly in HMLE cells that expressed the re-
spective transcription factors fused, in each case, to a modified
estrogen receptor (ER). Following activation of these fusion pro-
teins, achieved by addition of the ER ligand tamoxifen (4-OHT) to
these cells, we monitored the expression of the cell-surface
markers CD44 and CD24 and the acquisition of mammo-
sphere-forming ability.
Following tamoxifen addition, the HMLE-Snail-ER and HMLE-
Twist-ER cells developed a mesenchymal morphology similar to
HMLE cells stably expressing Snail or Twist (Figure S2A). More-
over, the great majority of HMLE-Snail-ER or Twist-ER cells
treated with tamoxifen for 12 days also showed increased
expression of vimentin (Figure S9). As anticipated, HMLE-
Snail-ER cells acquired a mesenchymal mRNA expression
profile, as evidenced by increased expression of the mRNAs en-
coding the N-cadherin, vimentin, and fibronectin proteins and
decreased expression of E-cadherin mRNA (Figure S2B). Similar
results were obtained with HMLE-Twist-ER cells (data not
shown). In addition, the tamoxifen-treated cells progressively
developed the CD44high/CD24low marker phenotype (Figure
S2C). In accord with the results cited earlier, following tamoxifen
treatment, these cells gradually acquired the ability to form in-
creased numbers of mammospheres when this latter trait was
measured subsequently in the absence of further tamoxifen
treatment (10-fold increase in Snail-ER and 81-fold increase
in Twist-ER) (Figure S2D). In addition, these mammospheres
contained mammosphere-forming stem cells that could be pas-
saged in vitro as mammospheres for at least one additional gen-
eration in the absence of tamoxifen (Figure S4D). Accordingly,Cell 133, 704–715, May 16, 2008 ª2008 Elsevier Inc. 705
Figure 1. The Epithelial-Mesenchymal Transition (EMT) Generates Cells with Properties of Stem Cells
(A) Phase-contrast images of HMLE cells expressing Snail, Twist, or the control vector, as well as HMLE cells treated with recombinant TGFb1 (2.5 ng/ml) for
12 days (bottom right).
(B) Relative expression of the mRNAs encoding E-cadherin, N-cadherin, vimentin, and fibronectin in HMLE cells induced to undergo EMT by the methods outlined
in (A), as determined by real-time RT-PCR. GAPDH mRNA was used to normalize the variability in template loading. The data are reported as mean ± SEM.
(C) FACS analysis of cell-surface markers, CD44 and CD24, in the cells described in (A).
(D) In vitro quantification of mammospheres formed by cells described in (A). The data are reported as the number of mammospheres formed/1000 seeded cells ±
SEM, (* - p < 0.05; *** - p < 0.001 compared to the control).the ability to seed mammospheres persisted in these cells after
functional inactivation of the EMT-inducing transcription factors
achieved by withdrawal of tamoxifen from their culture media.
Similar to immortalized human mammary epithelial cells,
tamoxifen-mediated activation of Snail in primary human mam-
mary epithelial cells resulted in the appearance of mesenchymal-
looking cells (Figure S3A), decreased expression of E-cadherin
(3-fold), and increased expression of fibronectin (3-fold)
and vimentin (1.5-fold) (Figure S3B and S3C). In addition, these
cells exhibited a greatly increased ability (10-fold) to form706 Cell 133, 704–715, May 16, 2008 ª2008 Elsevier Inc.mammospheres, as assayed once again in the absence of ongo-
ing tamoxifen treatment (Figures S3D and S3E). Collectively,
these data provided further evidence that untransformed human
mammary epithelial cells acquire stem cell characteristics fol-
lowing passage through an EMT.
CD44high/CD24low Cells Isolated from HMLEs Exhibit
Many Properties of Stem Cells
Since the cells that passed through an experimentally induced
EMT showed attributes of stem cells, we speculated that
naturally arising stem cells might exhibit phenotypes similar to
cells that have been caused to undergo an EMT. To test this no-
tion, we first fractionated the HMLE human mammary epithelial
cells based on their CD44/CD24 antigen marker profile
(Figure 2A) (Al-Hajj et al., 2003; Sleeman et al., 2006). We then
subjected these CD44high/CD24low and CD44low/CD24high cells
to the mammosphere assay. Indeed, the CD44high/CD24low cells
formed mammospheres efficiently (Figures 2B and 2C). In con-
trast, the CD44low/CD24high cells did not form mammospheres
(Figures 2B and 2C).
To test the self-renewal capability of the mammosphere-form-
ing cells, we dissociated the primary mammospheres into single
cells and performed secondary mammosphere assays. Interest-
ingly, we found 40 secondary mammospheres formed per
1000 seeded cells (4.0%). Moreover, the proportion of mammo-
sphere-forming cells isolated from already-formed mammo-
spheres remained the same (approximately 4%–6%) through
subsequent serial passages (Figure S4). This indicates that the
mammosphere-forming cells are capable of self-renewing and
the conditions of mammosphere culture encourage an increase
and subsequent stable maintenance of the number of self-
renewing cells among the larger population of HMLE cells.
To further investigate whether cells within such mammo-
spheres contain bipotential (i.e., luminal and basal/myoepithelial)
precursor cells, we introduced HMLEs into mammosphere cul-
tures at a clonal density to ensure that each of the resulting mam-
mospheres arose from a single stem cell and immunostained the
resulting mammospheres for the presence of a basal/myoepi-
thelial marker (cytokeratin 14) and the luminal epithelial markers
(cytokeratins 8 and 18). This staining revealed that the majority of
cells in each mammosphere expressed either the basal epithelial
marker cytokeratin 14 or the luminal epithelial markers cytoker-
atin 8 or 18; however, a minority cell population (5%) in these
mammospheres coexpressed basal and luminal cytokeratin
(Figure 2D). Together, these observations suggested that a single
mammosphere-forming cell can generate cells of both luminal
and basal lineages.
We transferred individual mammospheres into Matrigel culture
in order to test whether they could differentiate into secondary
structures (Dontu et al., 2003). These conditions of culture
revealed that the mammospheres differentiated and formed com-
plex secondary structures (Figure S5A). Remarkably, immunos-
taining of these secondary structures showed Muc1 (luminal
marker)-positive cells in the inner luminal layer and CD49f/integrin
a6-positive (basal marker) cells in the outer layer, similar to normal
mammary ducts (Gudjonsson et al., 2002; Stingl et al., 2006) (Fig-
ures S5B and S5C). These observations indicated that each mam-
mosphere contains a small percentage of bipotential progenitor
cells, as observed previously by others (Dontu et al., 2003).
We also wished to determine whether the CD44high/CD24low
cells isolated from monolayer cultures of HMLE cells could gen-
erate the CD44low/CD24high non-mammosphere-forming cells
in vitro. To do so, we introduced the FACS-purified CD44high/
CD24low cells into monolayer culture and assayed for the
appearance of a CD44low/CD24high population. Indeed, within 8
days these CD44high/CD24low cells developed into a cell popula-
tion containing a 71% CD44low/CD24high cells (Table S1). In
contrast, no CD44high/CD24low cells were generated by culturingthe sorted CD44low/CD24high cells in monolayer for the same
period of time (Table S1). This suggested a lineage hierarchy in
which CD44high/CD24low cells give rise to CD44low/CD24high cells
under these conditions of culture, the reverse conversion was
not observed. We confirmed and extended these findings by pu-
rifying single-cell clones from CD44high/CD24low and CD44low/
CD24high cell populations and observed similar behavior in vitro
(Table S2).
We also performed immunostaining to further determine
whether the mesenchymal-appearing CD44high/CD24low cells
were indeed bipotential precursor cells that could give rise to
populations containing a mixture of luminal cells, myoepithelial
cells, and a small subpopulation of bipotential cells. We found
that culturing of single-cell clones from the CD44high/CD24low
population indeed generated heterogeneous populations of cells
displaying either the luminal CK18 marker, the basal/myoepithe-
lial CK14 marker, or, in the case of a small minority of cells, both
luminal and basal/myoepithelial markers (CK14/18) simulta-
neously (Figure 2E). Conversely, the single-cell clones derived
from CD44low/CD24high cells expressed mainly the luminal cyto-
keratin (CK18), with a few cells at the outer edges of the epithelial
cell islands expressing the basal/myoepithelial marker (CK14).
We found no bipotential cells in single-cell clones derived from
the CD44low/CD24high cells (Figure 2E). These observations
further supported our conclusion that CD44high/CD24low cells
behave like bipotential precursor cells.
We further addressed the possibility that induction of an EMT
forces the conversion of CD44low/CD24high cells to stem-like
CD44high/CD24low by expressing the Snail or Twist protein in
FACS-sorted population of CD44low/CD24high cells or single-
cell clones derived from CD44low/CD24high cells. The majority
of these CD44low/CD24high cells underwent an EMT, as judged
by their morphology, and generated CD44high/CD24low cells (Fig-
ures S6A and S6C). In addition, the mesenchymal-appearing
cells derived de novo by inducing EMT in both the sorted
CD44low/CD24high population (Figure S6B) and the clonal
CD44low/CD24high population (Figure S6D) formed >10-fold
more mammospheres than did the sorted CD44low/CD24high
population and the clonal CD44low/CD24high population infected
with a corresponding control vector.
These observations, together with those cited earlier, indicate
that the mammosphere-forming CD44high/CD24low cells can self-
renew in vitro to generate more CD44high/CD24low cells as well as
give rise to non-mammosphere-forming CD44low/CD24high cells.
Conversely, the non-mammosphere-forming CD44low/CD24high
cells proliferated well in culture but could not form CD44high/
CD24low cells. This provided further evidence that the CD44high/
CD24low cells possess certain attributes of stem cells.
Stem-like Cells Express Markers Associated with EMT
To determine whether naturally present, stem-like CD44high/
CD24low cells exhibit phenotypes similar to cells that have under-
gone an EMT, we first introduced CD44high/CD24low and CD44low/
CD24high HMLE cells fractionated by FACS (Figure 2A) into mono-
layer culture. Of note, the CD44high/CD24low cells introduced
into monolayer culture exhibited mesenchymal morphology
(Figure 3A) similar to that of cells forced to undergo an EMT by
ectopic expression of either Twist or Snail (Figure 1A). Conversely,Cell 133, 704–715, May 16, 2008 ª2008 Elsevier Inc. 707
Figure 2. CD44high/CD24low Cells Exhibit Many Properties of Stem Cells
(A) CD44high/CD24low cells and CD44low/CD24high cells were separated by FACS.
(B) Phase-contrast images of mammospheres seeded by CD44high/CD24low (top) and CD44low/CD24high (bottom) cells.
(C) Quantification of mammospheres formed by cells from the sorted CD44high/CD24low and CD44low/CD24high populations. The data are reported as mean ±
SEM (p < 0.001).
(D) Images of mammospheres immunostained with antibodies against basal cytokeratin 14 (K14, red) and luminal cytokeratin 8 (K8, green, top panel) or
cytokeratin 18 (K18, green, bottom panel). In the merged images (right), the arrows indicate K8/K14 or K18/K14 double-positive cells (yellow).708 Cell 133, 704–715, May 16, 2008 ª2008 Elsevier Inc.
Figure 3. Stem-like CD44high/CD24low Cells Isolated from HMLE Cells Exhibit Attributes of Cells that Have Undergone an EMT
(A) Phase-contrast images (left) and immunofluorescence images of CD44high/CD24low and CD44low/CD24high cells stained using antibodies against E-cadherin,
fibronectin, or vimentin (right panels). (B) The expression levels of the mRNAs encoding E-cadherin, N-cadherin, vimentin, fibronectin, FOXC2, Slug, SIP1, Twist,
and Snail in CD44high/CD24low cells relative to CD44low/CD24high as determined by real-time RT-PCR. GAPDH mRNA was used to normalize the variability in
template loading. The data are reported as mean ± SEM.the CD44low/CD24high HMLE cells formed cobblestone cell is-
lands typical of epithelial cells (Figure 3A).
To learn whether these naturally present, cultured stem-like
CD44high/CD24low HMLE cells have gene expression character-
istics observed in epithelial cells that have passed through an
EMT, we used both immunofluorescence and real-time RT-
PCR to measure the expression of multiple EMT-associated
genes. Indeed, we found the expression levels of these EMT-
associated genes in CD44high/CD24low cells resembled the
levels seen in cells that have undergone EMT, while the expres-
sion levels of these genes in the CD44low/CD24high cells did not.
Specifically, relative to levels in the CD44low/CD24high cells, the
CD44high/CD24low cells exhibited a strong reduction in the E-
cadherin protein and a significantly increased expression of fi-
bronectin and vimentin (Figure 3A). Moreover, RT-PCR analyses
revealed that, relative to the expression in CD44low/CD24high
cells, the level of the E-cadherin mRNA in CD44high/CD24low cells
was strongly reduced (150-fold), while expression of mRNAsencoding mesenchymal markers was markedly increased,
specifically N-cadherin (200-fold), fibronectin (60-fold), and
vimentin (200-fold). There was also a considerable increase
in the expression of EMT-inducing transcription factors, specifi-
cally FOXC2 (16-fold), SIP1 (30-fold), Snail (9-fold), and
Twist (198-fold) (Figure 3B); Slug expression was only margin-
ally increased (1.5-fold) (Figure 3B) in these CD44high/CD24low
cells. These measurements provided further indication that the
CD44high/CD24low cells exist in a mesenchymal-like cell state
that closely resembles that of cells that have undergone an
EMT.
Normal Mouse Mammary Stem Cells Express Markers
Associated with an EMT
We also used the well-established CD49fhigh and CD24med (Stingl
et al., 2006) antigen phenotype to enrich for murine stem cells
(Figure 4A) in order to learn whether stem cells isolated directly
from mouse mammary tissues also express markers associated(E) Images of single-cell clones derived from CD44high/CD24low cells (left) or CD44low/CD24high cells (right) stained using antibodies against K14 (red) and K18
(green). The arrows indicate K14/K18 double-positive cells (yellow).Cell 133, 704–715, May 16, 2008 ª2008 Elsevier Inc. 709
with passage through an EMT. Indeed, as reported earlier (Stingl
et al., 2006), 1000 of the FACS-enriched CD49fhigh/CD24med cells
reconstituted cleared mouse mammary fat pads efficiently, while
1000 cells from the CD49fhigh/CD24med-depleted population
failed to do so (Figure 4B). We also found that cells in CD49fhigh/
CD24med population appeared mesenchymal in monolayer
culture when compared with the cells in the CD49fhigh/
CD24med-depleted populations (Figure 4C).
Similar to observations described above, compared with the
CD49fhigh/CD24med-depleted cells, the mesenchymal-appear-
ing CD49fhigh/CD24med cells expressed a number of markers
associated with passage through an EMT, notably reduced ex-
pression of E-cadherin (10-fold), an increased expression of
N-cadherin (10-fold) and vimentin (6-fold), as well as a signif-
Figure 4. Primary Mouse Mammary Stem
Cells, Normal Human Breast Stem-like
Cells, and Neoplastic Human Breast Stem-
like Cells Express Markers Associated
with an EMT
(A) Primary mouse mammary epithelial cells were
separated into CD49fhigh/CD24med and
CD49fhigh/CD24med-depleted populations using
FACS.
(B) A representative image of a cleared mouse
mammary fat pad reconstituted using 1000 of
CD49fhigh/CD24med cells (top); the same number
of CD49fhigh/CD24med-depleted cells failed to
reconstitute the fat pad (bottom).
(C) Phase-contrast images of CD49fhigh/CD24med
and CD49fhigh/CD24med-depleted cells.
(D) The expression levels of the mRNAs encoding
E-cadherin, N-cadherin, vimentin, Slug, and Twist
in the CD49fhigh/CD24med relative to CD49fhigh/
CD24med-depleted cells, as determined by real-
time RT-PCR. GAPDH mRNA was used to normal-
ize variability in template loading. The data are
reported as mean ± SEM.
(E) CD44high/CD24low cells (R4) and CD44low/
CD24high cells (R3) were isolated from human
reduction mammoplasty tissues using FACS.
(F) The expression levels of the mRNAs encoding
E-cadherin, N-cadherin, SIP-1, and FOXC2 in
CD44high/CD24low cells (R4) relative to CD44low/
CD24high cells (R3), as determined by real-time
RT-PCR. GAPDH mRNA was used to normalize
the variability in template loading. The data are
reported as mean ± SEM.
(G) Heat map depicting the expression levels of
mRNAs encoding EMT markers in CD44high/
CD24low cells compared to CD44low/CD24high
cells, as determined by SAGE analysis. Red and
green squares correspond to high and low
mRNA levels, respectively.
icant increase in the EMT-inducing tran-
scription factors Twist (1.6-fold) and
Slug (36-fold) relative to CD49fhigh/
CD24med-depleted cells (Figure 4D).
Once again, a population of cells en-
riched for stem cell activity exhibited a
mesenchymal morphology and expressed markers associated
with cells that have undergone an EMT.
Normal and Neoplastic Human Breast Stem-like Cells
Express Markers Associated with an EMT
We proceeded to extend these analyses to human mammary
epithelial cells isolated directly either from reduction mammo-
plasties or breast carcinomas. We initially isolated CD44high/
CD24low and CD44low/CD24high mammary epithelial cells from
normal reduction mammoplasty tissues (Figure 4E) and, as be-
fore, gauged their mRNA expression pattern using real-time
RT-PCR. The CD44high/CD24low cells expressed low levels of
E-cadherin mRNA, high levels of N-cadherin mRNA, and ele-
vated levels of the mRNAs specifying two key EMT-inducing710 Cell 133, 704–715, May 16, 2008 ª2008 Elsevier Inc.
Table 1. The Sequence of SAGE Tags Specific for Known EMTGenes and the Numbers of Each Tags Present in CD44high/CD24low and
CD44low/CD24high Populations Isolated from Normal and Neoplastic Human Mammary Glands
SAGE Tag
CD44high/CD24low CD44low/CD24high
Gene NameNormal Tumor Normal Tumor
TGTGGGTGCTGATAATT 18 0 0 8 8 22 115 18 34 12 81 78 CDH1 (E-cadherin)
ATCTTGTTACTGTGATA 7 30 46 30 91 26 0 0 0 0 0 0 FN1 (Fibronectin 1)
TCCAAATCGATGTGGAT 1038 642 332 504 472 300 101 71 5 0 0 0 VIM (Vimentin)
TGCGTCCCGCCCGCCCT 4 2 0 0 0 0 0 0 0 0 0 0 FOXC2
GAATTCCCTCCTGAGTG 11 0 0 4 4 0 0 0 0 0 0 0 SNAI1 (Snail)
CTCCATTGTCTTACTAT 0 5 4 0 4 4 0 0 0 0 0 0 SNAI2 (Slug)
GTAGATGCAAGGGAAAC 0 0 0 0 4 0 0 5 0 0 0 0 TCF-3 (Transcription factor 3)
GTAAAATGCAAATAGAT 18 15 0 0 4 22 0 3 0 0 0 0 Twist1 (Twist homolog 1)
ATTGTTTCAAGTCAGCC 0 10 4 15 15 7 0 0 0 0 0 0 Twist2 (Twist homolog 2)
CTCGAATAAAAATGTAG 39 42 57 0 15 30 0 0 0 0 0 0 ZFH1B
(Zinc finger homeobox 1b)
The tumors samples were prepared from two invasive ductal carcinomas, one pleural effusion, and one ascites; the normal samples were prepared
from two reduction mammoplasties.transcription factors—SIP1 and FOXC2—relative to the expres-
sion levels of the respective mRNAs in the CD44low/CD24high
population (Figure 4F).
To extend and generalize these results, we isolated CD44high/
CD24low cells and CD44low/CD24high cells from three normal re-
duction mammoplasty tissues and from five neoplastic human
breast tissues and carried out serial analysis of gene expression
(SAGE)—an alternative method of gauging the spectrum of
mRNAs expressed within tissues (Shipitsin et al., 2007). Rela-
tive to the CD44low/CD24high cells, the CD44high/CD24low cells
expressed high levels of the mRNAs encoding mesenchymal
markers, specifically CDH2 (N-cadherin), VIM (Vimentin), FN1
(Fibronectin), ZEB2 (SIP-1), FOXC2, SNAIL1 (Snail), SNAIL2
(Slug), TWIST1 and TWIST2, and a low level of theCDH1I (E-cad-
herin) mRNA (Figure 4G and Table 1). These data indicate that
the CD44high/CD24low cells isolated from cultured immortalized
MECs as well as from normal and neoplastic human tissue sam-
ples express multiple genes associated with cells that have
undergone an EMT.
EMT Promotes the Generation of Cancer Stem Cells
The above observations suggested mammary epithelial stem-like
cells could be generated from more differentiated populations of
normal mammary epithelial cells by inducing an EMT. By exten-
sion, we speculated that EMT could promote the generation of
cancer stem cells from more differentiated neoplastic cells. To
address this possibility, we induced an EMT in experimentally
immortalized human mammary epithelial cells (Elenbaas et al.,
2001; Hahn et al., 1999) that had been transformed by introduc-
tion of an activated form of the HER2/neu oncogene (HMLEN
cells). These cells were also infected with a vector expressing
the tamoxifen-activatable form of either the Snail (Snail-ER) or
the Twist (Twist-ER) transcription factors as described earlier.
These cells underwent an EMT when treated with tamoxifen
for 10 days in monolayer culture (Figures 5A and 5B), similar to
the behavior of the immortalized, untransformed precursors of
these HER2/neu-transformed cells described earlier (Figures
S2A and S2B). Following withdrawal of tamoxifen, we subjectedthese HMLEN cells to both soft agar and tumor sphere assays in
the absence of tamoxifen; the first of these assays serves as an
in vitro surrogate measure of tumorigenicity (Cifone and Fidler,
1980; Singh et al., 2004), while the second gauges stemness. In-
terestingly, we observed that the cells that had undergone an
EMT following tamoxifen treatment formed at least 10-fold
more tumor spheres than did control cells that had not been
exposed to tamoxifen (Figure 5C). Equally important, the trans-
formed cells that underwent an EMT formed 10-fold more
colonies in soft agar suspension culture than did the control,
untreated cells (Figure 5D).
In order to gauge the tumorigenicity of the transformed cells
that have undergone an EMT, we injected HMLEN cells that
carried either Snail-ER or Twist-ER and had been treated with
4-OHT for 12 days prior to implantation in limiting dilutions into
subcutaneous sites of mouse hosts. These cells failed to form tu-
mors more efficiently than untreated cells in vivo, which sug-
gested that long-term maintenance of the EMT/stem cell state
depends on continuous EMT-inducing signals, at least in this ex-
perimental model. To test this notion further, we cultured the
HMLEN cells that had undergone an EMT in vitro for an additional
15 days in the absence of 4-OHT. These cells reverted com-
pletely back to an epithelial phenotype (Figure S10), suggesting
that maintenance of the stem cell state by these cells depends,
at least in vitro, on continuous EMT-inducing signals.
In order to test whether the constitutive expression of an EMT-
inducing transcription factor succeeded in altering the tumor-ini-
tiating frequency of transformed cells, we injected HMLER cells
(i.e., HMLE cells transformed with a V12H-Ras oncogene to ren-
der them tumorigenic [Elenbaas et al., 2001]) constitutively ex-
pressing either Snail or Twist into immunodeficient hosts. Similar
to the previously observed behavior of HMLE cells, both Snail
and Twist induced EMTs in these HMLER cells and increased
the number of CD44high/CD24low cells and the ability to form
mammospheres (Figure S7). The majority of the mice that were
injected with 103 Twist- or Snail-expressing HMLER cells formed
tumors (6 of 9, Snail; 7 of 9, Twist), while no tumors arose when
an equal number of cells expressing a control vector wereCell 133, 704–715, May 16, 2008 ª2008 Elsevier Inc. 711
injected into mice (Table 2). In fact, 105 of the control cells (lack-
ing either Twist or Snail expression) were required to initiate
tumor formation, and even then, tumor formation was inefficient
(3 of 9 injected hosts). Hence, expression of either the Twist or
Snail EMT-inducing transcription factor significantly increased
(by approximately two orders of magnitude) the number of
tumor-initiating cells. The histology of the tumors developed
Figure 5. EMT Induces Phenotypes Associated
with Cancer Stem Cells
(A) Phase-contrast images of NeuNT-Snail-ER, NeuNT-
Twist-ER, and NeuNT-control vector cells treated with
tamoxifen for a period of 10 days as well as images of
untreated cells.
(B) Western blot analysis of expression of HER2/neu,
E-cadherin, fibronectin, and vimentin proteins in the cells
shown in (A). b-actin was used as a loading control.
(C) Quantification of the mammospheres seeded by
NeuNT-Snail-ER, NeuNT-Twist-ER, or NeuNT-control
vector cells treated or not treated with tamoxifen for
10 days. The data are reported as mean ± SD.
(D) Images of the colonies formed during soft agar culture
of NeuNT-Snail-ER, NeuNT-Twist-ER, and NeuNT-control
vector cells after being treated with tamoxifen for 10 days.
The soft agar assays were performed in the absence of
tamoxifen.
(E) Quantification of the soft agar colonies shown in (D).
The data are reported as mean ± SD (** - p < 0.01; *** - p <
0.001 compared to the control).
from both the control cells and the cells ex-
pressing Snail or Twist appeared as squamous
metaplasias, similar to that of the tumors
formed by the parental cells (Figure S8), as re-
ported earlier (Elenbaas et al., 2001).
DISCUSSION
The findings presented here describe an unex-
pected convergence of two lines of recent re-
search; stem cells have been documented in
a variety of normal tissues, and more recently
this paradigm was extended to neoplasias
(Clarke et al., 2006; Reya et al., 2001). Indepen-
dent of these discoveries, the epithelial-mesen-
chymal transition (EMT) has been described
over the past decade as a cell-biological pro-
gram that is required for the remodeling of
cells and tissues during embryogenesis, during
certain types of wound healing, and during the
acquisition of malignant traits by carcinoma
cells (Hay, 2005; Thiery, 2003). None of these
findings hinted at a link between these two
sets of phenomena.
The discovery that the EMT generates cells
with many of the properties of self-renewing
stem cells holds the promise of resolving a
major problem in cancer biology. Many types
of cancer cells leaving primary carcinomas ap-
pear to rely on the EMT program to facilitate execution of most
of the steps of the invasion-metastasis cascade (Thiery, 2003).
However, the last step, termed colonization, which involves the
growth of micrometastases into macroscopic metastases, has
represented a conceptual dilemma: If the vast majority of cells
leaving a primary tumor and disseminating to distant sites lack
self-renewal capability, their ability to found macroscopic712 Cell 133, 704–715, May 16, 2008 ª2008 Elsevier Inc.
metastases is compromised from the outset because of their
limited proliferative potential. This factor would dictate that
successful formation of a macroscopic metastasis is an ex-
ceedingly rare event. This problem may be addressed, at least
in part, by the present findings, since the EMT program that
enables cancer cells to disseminate from a primary tumor also
promotes their self-renewal capability. Indeed, just such a con-
nection between metastasis and stem cell state has previously
been proposed in a speculative voice as a means of enabling
the formation of macroscopic metastases (Brabletz et al., 2005).
While the present work indicates that the EMT confers many of
the properties of the normal and neoplastic stem cell state, it
does not yet demonstrate all of them. In the case of normal mam-
mary stem cells, the case for the EMT leading to a stem cell state
has been supported, only indirectly: the EMT leads to great in-
creases in the number of self-renewing cells that can initiate
the seeding of mammospheres and, as shown by others and our-
selves, mammospheres are enriched in stem cells and can seed
entire mammary epithelial trees when implanted into cleared
mammary fat pads (Table S3) (Liao et al., 2007; Liu et al., 2006;
Moraes et al., 2007). A more direct demonstration of this point
will depend on a transient induction of an EMT in explanted
mammary epithelial cells, and the demonstration that, at various
limiting dilutions, such an induction leads to substantial in-
creases in mammary gland-repopulating cells upon implantation
into cleared mammary fat pads.
In principle, some of the presently observed behaviors of the
HMLE human mammary epithelial cells might be attributable to
the introduced genes that were used previously to immortalize
these cells, specifically hTERT, which encodes the catalytic sub-
unit of the human telomerase holoenzyme, as well the SV40 early
region. For example, these genes might facilitate the reprogram-
ming of the HMLE cells initiated by EMT-inducing transcription
factors such as Snail or Twist. However, we observe exactly
the same responses to Snail or Twist in nonimmortalized primary
mammary epithelial cells, which indicates that the hTERT and
SV04 T antigens appear to have no effect on the induction of
the EMT.
An analogous demonstration of the connection between the
EMT and the generation of neoplastic stem cells is also still
required. We have shown here that the induction of an EMT in
transformed human mammary epithelial cells yields cells with
a CD44high/CD24low antigenic phenotype; others have shown,
and we have confirmed, that such cells are greatly enriched in tu-
mor-initiating cells. (Al-Hajj et al., 2003; W.G., S.A.M., F.R., and
R.A.W., unpublished data). We have also demonstrated that
the number of tumor-initiating cells is increased by at least two
orders of magnitude if transformed cells were forced to constitu-
Table 2. Tumor Incidence of Transformed HMLEs Induced to
Undergo EMT by Ectopic Expression of Snail or Twist and Then
Injected into Host Mice in Limiting Dilutions
Cells Injected
Tumors Incidence/Number of Injections
1 3 106 1 3 105 1 3 104 1 3 103
HMLE-Vector-Ras 2/6 3/9 0/9 0/9
HMLE-Snail-Ras 6/6 9/9 9/9 6/9
HMLE-Twist-Ras 6/6 9/9 9/9 7/9tively express either a Twist or Snail EMT-inducing transcription
factor. However, in the end a more definitive test of the connec-
tions between the EMT and tumor-initiating ability will come from
inducing an EMT through activation of Twist-ER or Snail-ER in
transformed cells ex vivo followed by tests of their tumorigenicity
in vivo in the absence of ongoing Twist or Snail activity.
We note that the transient induction in mammary epithelial
cells of the EMT yields great increases in their ability to form
mammospheres. Since this capability can be transmitted
through repeated cycles of serial passage of mammosphere-
forming cells from one culture to the next, it seems apparent
that the transient induction of an EMT creates a heritable, self-
renewing state that continues to be manifest in the distant
lineal descendants of a cell that is initially forced to undergo an
EMT, indeed long after the EMT-inducing stimulus has been
removed.
The presently described connections appear to hold a number
of implications for the biology of epithelial cells. Thus, they sug-
gest that the stem cells of certain epithelial organs show many of
the attributes of the mesenchymal cell state. Moreover, the tran-
sient induction of an EMT in large populations of cancer cells
may make possible the generation of relatively unlimited num-
bers of cancer stem cells, whose biology may then be studied
with far greater facility. Perhaps more importantly, the use of
genetic or pharmacologic techniques to transiently induce an
EMT in large populations of differentiated normal epithelial cells
may provide a means of generating at will large numbers of
tissue-reconstituting, normal epithelial stem cells.
EXPERIMENTAL PROCEDURES
Cell Culture
The immortalized human mammary epithelial cells (HMLE) were maintained as
previously described (Elenbaas et al., 2001). For 4-hydroxy tamoxifen (4-OHT)
treatment, the HMLE-Snail-ER or Twist-ER cells were exposed to 4-OHT at
final concentration of 20 nM for the indicated number of days. For TGFb1
treatment, the HMLE cells were cultured in DME: F12 media (1:1) supple-
mented with insulin, EGF, hydrocortisone, and 5% calf serum and treated
with 2.5 ng/ml of TGFb1 for 12 days. Freshly sorted primary mouse
mammary epithelial cells were cultured in MM+ medium (1:1 ratio of DME/
F12, 10 ng/ml of EGF, 10 ug/ml of insulin, 1% bovine serum albumin, and
2% calf serum). Cultured cells were photographed on day 2. The plasmids
used in this study, procedures used to produce virus, the procedure for the in-
fection of target cells, and the derivation of different cell lines and their culture
conditions are provided as Supplemental Experimental Procedures.
Antibodies, Western Blotting, and Immunofluorescence
Cells were lysed in the presence of 50 mM Tris, pH 7.5, 150 mM NaCl, and
0.5% NP-40 on ice. Fifty micrograms of total protein from each sample was
resolved on a 4%–12% Bis-Tris Gel with MOPs Running Buffer and transferred
to PVDF membranes. The blots were then probed with various antibodies,
such as anti-b-actin (Abcam), anti-E-cadherin (BD Transduction), anti-Fibro-
nectin (BD Transduction), anti-vimentin V9 (NeoMarkers), or anti-N-cadherin
(BD Transduction). Detailed immunofluorescence methods are also given in
the Supplemental Experimental Procedures.
Mammosphere Culture and Differentiation
Mammosphere culture was performed as described in Dontu et al. (2003) with
slight modification, as described in Supplemental Experimental Procedures.
The mammosphere differentiation assay was adopted from Weaver and Bis-
sell (1999) and Dontu et al. (2003). Essentially, single mammospheres were
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supplemented with 10 ng/ml FGF, 4 ng/ml heparin and 2 ug/ml prolactin for
additional 10–14 days. The structures were then photographed and embedded
in OCT for sectioning and immunofluorescence analysis.
Soft Agar and Tumorigenesis Assays
Soft agar assays were performed as described previously (Cifone and Fidler,
1980). Cultures were photographed, and the colonies with diameters larger
than 500 mm were counted using ImageJ software (previously NIH image).
Aliquots of 105, 104, and 103 HMLE-Snail-Ras , HMLE-Twist-Ras, or HMLE-
Vector-Ras cells were injected subcutaneously into athymic nude mice. The
tumor incidence was monitored for 25 days following injection. All mouse
procedures were preapproved by the Animal Care and Use Committee of
the Massachusetts Institute of Technology and performed according to
institutional policies.
Reverse Transcriptase PCR Analysis
SYBR-Green real-time RT-PCR and the corresponding data analysis were de-
scribed earlier (Yang et al., 2004). For all RT-PCR analysis GAPDH mRNA was
used to normalize RNA inputs. Primers sequence used to amplify genes are
listed in the Supplemental Experimental Procedures.
FACS Analysis
The anti-CD44 (clone G44-26) and anti-CD24 (clone ML5) antibodies used for
FACS analysis were obtained from BD Bioscience. To sort primary mouse
mammary epithelial cells, mouse mammary glands were digested with colla-
genase (1 mg/ml), and the organoids were collected by brief centrifugation
(800 rpm for 45 s). The organoids were digested with 0.025% trypsin for
5 min at 37C in order to dissociate into single cells. The dissociated cells
were stained with antibodies against CD49f (PharMingen) and CD24 (PharMin-
gen) and several lineage markers (CD45, CD31, Ter-119 and CD140a
[eBioscience]), as described in Stingl et al. (2006). The Lin cells were used
for sorting.
Primary Human Samples and SAGE Libraries
CD44high/CD24low and CD44low/CD24high cells were isolated from normal re-
duction mammoplasty tissues and breast tumors by sequential capturing of
cell types with antibody-coupled beads specific for various cell markers (Shi-
pitsin et al., 2007). Fresh tissue samples were collected from Harvard-affiliated
hospitals, and cell fractions were immediately purified. Three normal tissues,
one pleural effusion, two ascites, and three invasive ductal carcinomas were
collected in triplicate from different patients. Specimens were collected
without patient identifiers following protocols approved by the Dana-Farber
Cancer Institute Institutional Review Board.
Heat Map
The heat map in Figure 4C was produced using the SAGE tag counts in Table
1, which were visualized using MapleTree (developed by L. Simirenko). Before
visualization, tag counts were log2-transformed (treating a count of 0 as if it
were 1), median-centered by tag, and subjected to hierarchical complete
linkage clustering by tags and SAGE libraries with uncentered correlation
similarity metrics using Cluster (Eisen et al., 1998).
Statistical Analysis
All data are presented as mean ± SEM except stated. When two groups were
compared, the Student’s t test was used (p < 0.05 was considered significant).
SUPPLEMENTAL DATA
Supplemental Data include ten figures, three tables, Supplemental Experimen-
tal Procedures, and Supplemental References and can be found with this
article online at http://www.cell.com/cgi/content/full/133/4/704/DC1/.
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